Our new enzymatic DNA synthesis technology opens new territory for previously unimagined sequences to come into being.
We synthesize complex gene sequences accurately and reliably. With our novel enzymatic DNA synthesis technology, we can deliver complex DNA sequences that include repeats, secondary structure, GC or AT rich, and other difficult to synthesize sequences.
We have discovered a way of synthesizing DNA using enzymes, without damaging DNA in the process.
Your imagination is free to roam with our ability to synthesize complex DNA sequences.
We are on track to bring you the longest DNA oligonucleotides available, “Ansamers”.
Ansa’s novel DNA manufacturing platform overcomes challenges of stitching together many short oligonucleotides by instead directly synthesizing ultra-long oligonucleotides that include complex sequences.
In April 2023, Ansa Biotechnologies introduced a limited Early Access Program-. Early Access participants have access to Ansa’s DNA synthesis service for clonal, sequence-perfect DNA constructs made using Ansa’s revolutionary DNA synthesis technology before it is commercially available.
Revolutionizing human health by enabling cell and gene therapies, novel biologics, and vaccine development.
Enhancing metabolite production in medicine and biotechnology by optimizing cellular pathways and processes.
Addressing complex agricultural Issues related to food, crops, livestock and the environment through the application of synthetic engineering breakthroughs.
Designing tailored platforms to unlock the potential of enzymes and microorganisms to better produce biobased products and advance sustainable practices.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.

March 22, 2023 – PRESS RELEASE
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et.
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!